LGC have a wealth of experience in detection and quantitation of biomarkers in a wide variety of matrices.
More than 200 dedicated scientists work in one the world’s largest bioanalytical facilities with a broad range of analytical platform.
LGC's biomarker services can be adapted to your specific requirements:
LGC have extensive experience with a range of biomarkers, including those linked to:
LGC have a range of analytical platforms for LGC's biomarker methodologies, using both ligand binding assays, flow cytometry and mass spectrometry, in a multitude of matrix types: